UpHealth Q3 Adj EPS $2.92, Sales $32.70M Down From $38.67M YoY
Portfolio Pulse from Benzinga Newsdesk
UpHealth reported its Q3 adjusted EPS at $2.92, with sales reaching $32.70M, a decrease from the previous year's $38.67M.
November 20, 2023 | 10:42 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
UpHealth's Q3 earnings showed a decline in sales from $38.67M to $32.70M year-over-year, although the adjusted EPS was $2.92.
The decrease in sales year-over-year is typically viewed negatively by investors as it may indicate a slowdown in the company's business. While the EPS is positive, the decline in revenue is likely to have a more significant impact on investor sentiment in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100